Thiazide diuretics and primary hyperparathyroidism.

Hypercalcaemia Hyperparathyroidism Thiazide diuretics

Journal

British journal of hospital medicine (London, England : 2005)
ISSN: 1750-8460
Titre abrégé: Br J Hosp Med (Lond)
Pays: England
ID NLM: 101257109

Informations de publication

Date de publication:
02 Dec 2023
Historique:
medline: 28 12 2023
pubmed: 28 12 2023
entrez: 28 12 2023
Statut: ppublish

Résumé

Thiazide diuretics exert a natriuretic and diuretic effect by inhibiting sodium reabsorption in the distal convoluted tubule. Furthermore, thiazide diuretics affect renal calcium handling by increasing calcium reabsorption, leading to hypocalciuria. The effect that thiazide diuretics exert on parathyroid hormone secretion is controversial. Some studies found parathyroid hormone levels were suppressed with the use of thiazide diuretics, while others found that thiazides were associated with initial parathyroid hormone suppression followed by raised parathyroid hormone levels. This makes the relationship between thiazide diuretics and primary hyperparathyroidism interesting. If a patient is taking thiazide diuretics, this may make it harder to establish the aetiology of hypercalcaemia and may unmask normocalcaemic or mild primary hyperparathyroidism. Thiazide diuretics may have a beneficial role in the diagnosis of patients with concomitant hyperparathyroidism and hypercalciuria by distinguishing secondary hyperparathyroidism caused by hypercalciuria from normocalcaemic primary hyperparathyroidism. In addition, thiazide diuretics may have a role in managing patients with primary hyperparathyroidism who have an indication for parathyroidectomy in view of significant hypercalciuria, but are unfit for surgery.

Identifiants

pubmed: 38153014
doi: 10.12968/hmed.2023.0228
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Auteurs

Simon Mifsud (S)

Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.

Gabriella Montanaro (G)

Department of Medicine, Mater Dei Hospital, Msida, Malta.

Sarah Craus (S)

Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.

Emma L Mifsud (EL)

Department of Medicine, Mater Dei Hospital, Msida, Malta.

Mark Gruppetta (M)

Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.

Classifications MeSH